Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin

Item Number: BIOV4706-100
Unit of Measure: 100 MCG
https://grogg-prod.braintec.cloud/web/image/product.template/925948/image_1920?unique=134b63c

240.00 CHF 240.0 CHF 240.00 CHF

240.00 CHF

Not Available For Sale

    This combination does not exist.

    Aktuelle Lieferfrist auf Anfrage

    Manufacturer: BIOVISION
    Manufacturer Number: 4706-100
    Storage Temperature: Freezer (-80)

    Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin